Ligand Pharmaceuticals Incorporated (LGND) — Cash Flow-to-Debt Ratio
Ligand Pharmaceuticals Incorporated (LGND) has a Cash Flow-to-Debt Ratio of 0.09x as of March 2026, meaning its operating cash flow of $48.69 Million could theoretically repay 0% of its total liabilities ($534.78 Million) in one year. Explore investment intensity of Ligand Pharmaceuticals Incorporated to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Ligand Pharmaceuticals Incorporated Cash Flow-to-Debt Ratio (1994–2025)
Historical debt coverage capacity for Ligand Pharmaceuticals Incorporated across 32 annual periods. Also explore how large is Ligand Pharmaceuticals Incorporated's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Ligand Pharmaceuticals Incorporated (1994–2025)
Year-by-year debt coverage analysis for Ligand Pharmaceuticals Incorporated. For market capitalisation and broader financial context, see market cap of Ligand Pharmaceuticals Incorporated.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | $49.36 Million | $543.42 Million | ▼ -89.6% |
| 2024 | 0.87x | $97.05 Million | $111.33 Million | ▲ +51.7% |
| 2023 | 0.57x | $49.58 Million | $86.30 Million | ▼ -31.2% |
| 2022 | 0.83x | $137.85 Million | $165.18 Million | ▲ +404.6% |
| 2021 | 0.17x | $78.80 Million | $476.43 Million | ▲ +97.8% |
| 2020 | 0.08x | $54.59 Million | $652.76 Million | ▲ +307.4% |
| 2019 | -0.04x | $-29.34 Million | $727.68 Million | ▼ -114.5% |
| 2018 | 0.28x | $194.06 Million | $699.89 Million | ▼ -25.2% |
| 2017 | 0.37x | $93.57 Million | $252.37 Million | ▲ +35.8% |
| 2016 | 0.27x | $63.00 Million | $230.73 Million | ▲ +50.2% |
| 2015 | 0.18x | $41.73 Million | $229.54 Million | ▲ +106.5% |
| 2014 | 0.09x | $20.57 Million | $233.62 Million | ▼ -76.6% |
| 2013 | 0.38x | $20.69 Million | $55.10 Million | ▲ +18039.4% |
| 2012 | 0.00x | $161.00K | $77.78 Million | ▲ +120.1% |
| 2011 | -0.01x | $-1.17 Million | $113.70 Million | ▲ +96.9% |
| 2010 | -0.33x | $-27.07 Million | $82.55 Million | ▼ -6.7% |
| 2009 | -0.31x | $-33.80 Million | $109.95 Million | ▼ -171.0% |
| 2008 | -0.11x | $-20.62 Million | $181.81 Million | ▲ +83.3% |
| 2007 | -0.68x | $-97.73 Million | $144.16 Million | ▼ -46.2% |
| 2006 | -0.46x | $-138.52 Million | $298.70 Million | ▼ -2456.4% |
| 2005 | 0.02x | $8.37 Million | $425.04 Million | ▲ +39.5% |
| 2004 | 0.01x | $5.75 Million | $407.78 Million | ▲ +1087.2% |
| 2003 | 0.00x | $274.00K | $230.53 Million | ▲ +100.9% |
| 2002 | -0.13x | $-25.11 Million | $196.59 Million | ▼ -12.5% |
| 2001 | -0.11x | $-19.91 Million | $175.35 Million | ▲ +59.6% |
| 2000 | -0.28x | $-47.35 Million | $168.55 Million | ▲ +25.6% |
| 1999 | -0.38x | $-60.50 Million | $160.20 Million | ▲ +5.1% |
| 1998 | -0.40x | $-66.60 Million | $167.40 Million | ▼ -117.0% |
| 1997 | -0.18x | $-13.40 Million | $73.10 Million | ▲ +62.8% |
| 1996 | -0.49x | $-33.30 Million | $67.60 Million | ▲ +14.9% |
| 1995 | -0.58x | $-37.90 Million | $65.50 Million | ▲ +17.5% |
| 1994 | -0.70x | $-14.30 Million | $20.40 Million | — |